Davis Selected Advisers Trims Stock Holdings in CVS Health Corporation $CVS

Davis Selected Advisers lessened its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.6% in the third quarter, Holdings Channel.com reports. The institutional investor owned 11,403,641 shares of the pharmacy operator’s stock after selling 183,149 shares during the quarter. CVS Health makes up 4.5% of Davis Selected Advisers’ portfolio, making the stock its 6th largest holding. Davis Selected Advisers’ holdings in CVS Health were worth $859,720,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Foundations Investment Advisors LLC grew its holdings in shares of CVS Health by 13.3% during the second quarter. Foundations Investment Advisors LLC now owns 9,333 shares of the pharmacy operator’s stock valued at $644,000 after purchasing an additional 1,096 shares during the last quarter. Vanguard Group Inc. lifted its holdings in shares of CVS Health by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after purchasing an additional 2,063,737 shares during the last quarter. Wealthspire Advisors LLC boosted its position in CVS Health by 10.4% during the 2nd quarter. Wealthspire Advisors LLC now owns 18,278 shares of the pharmacy operator’s stock valued at $1,261,000 after purchasing an additional 1,728 shares during the period. Birchbrook Inc. grew its stake in CVS Health by 5.2% during the 2nd quarter. Birchbrook Inc. now owns 5,795 shares of the pharmacy operator’s stock worth $400,000 after buying an additional 288 shares during the last quarter. Finally, Traub Capital Management LLC acquired a new stake in CVS Health in the second quarter worth $722,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE CVS opened at $73.03 on Thursday. The stock has a market cap of $92.91 billion, a P/E ratio of 52.92, a P/E/G ratio of 0.78 and a beta of 0.49. The firm’s 50-day simple moving average is $77.83 and its 200 day simple moving average is $77.83. CVS Health Corporation has a fifty-two week low of $58.35 and a fifty-two week high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last announced its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. During the same quarter in the prior year, the firm posted $1.19 EPS. CVS Health’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio (DPR) is currently 192.75%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CVS. Royal Bank Of Canada reiterated an “outperform” rating on shares of CVS Health in a research note on Thursday, December 4th. Leerink Partners reaffirmed an “outperform” rating and issued a $98.00 price objective on shares of CVS Health in a report on Thursday, March 5th. The Goldman Sachs Group lifted their price objective on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. UBS Group restated an “outperform” rating on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Piper Sandler restated an “overweight” rating and issued a $101.00 price target (up from $99.00) on shares of CVS Health in a research note on Wednesday, December 10th. Twenty research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $95.05.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.